PDL BioPharma Mergers and Acquisitions Summary

Life Science Company

PDL BioPharma has acquired 4 companies, including 1 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.

It’s largest disclosed sale occurred in 2020, when it sold Noden Pharma DAC to Stanley Capital for $53M. PDL BioPharma has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (75%) and medical products (25%).

Join Mergr and gain access to PDL BioPharma’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity4
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 3

PDL BioPharma

PDL BioPharma, Inc.

932 Southwood Boulevard,
Incline Village, Nevada 89451
United States,
(775) 832-8500
www.pdl.com

PDL BioPharma is a portfolio of patents and royalty assets, consisting primarily of its Queen et al. antibody humanization patents and license agreements with various biotechnology and pharmaceutical companies. PDL BioPharma was founded in 1986 and is based in Incline Village, Nevada.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.2/yr) # 3 1 - - - - 4
Sell (0.2/yr) # - - - - 1 - 1
vol $53M $53M
  5

Most Recent M&A

Company Date Value Type
Noden Pharma DAC 2020-09-09 53M USD Divestiture
Dublin, Ireland · www.nodenpharma.com
Neos Therapeutics, Inc. 2017-10-26 - Add-on Acquisition
Grand Prairie, Texas · www.neostx.com
Depomed - Diabetes Royalty Rights 2015-11-04 - Divestiture
, United States
ESP Pharma, Inc. 2006-01-09 - Add-on Acquisition
Edison, New Jersey
Eos Biotechnology, Inc. 2003-02-04 - Add-on Acquisition
South San Francisco, United States
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (75%) - 1 (100%) 53M (100%)
Medical Products 1 (25%) - - -
Total 4 - 1 $53M

By Geo

State/Country Buy Value Sell Value
United States 3 - - -
  New Jersey 1 - - -
Ireland - - 1 53M
United Kingdom 1 - - -
  Texas 1 - - -
Domestic 3 (75%) - - -
Cross-border 1 (25%) - 1 (100%) 53M (100%)
Total 4 - 1 $53M

Deal Values

sell # Total
< $100M 1 $53M
TOTAL $53M
Largest Noden Pharma DAC
$53M (2020-09-09)

M&A Connections

Deals
Acquired from
Investor(s)
25%
1 (25%)
Strategic(s)
25%
1 (25%)
Divested to
Investor(s)
100%
1 (100%)

 Subscribe to unlock this and 166,937
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 156K M&A Transactions
  • 163K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.3K M&A Advisors
    (Investment Banks and Law Firms)
  • 55K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.